Health and Fitness Health and Fitness
Mon, July 12, 2010
Fri, July 9, 2010
Thu, July 8, 2010

Kendall Law Group Investigates LHC Group for Shareholders


Published on 2010-07-09 02:00:54 - Market Wire
  Print publication without navigation


DALLAS--([ BUSINESS WIRE ])--[ Kendall Law Group ], a national securities firm led by a former federal judge and a former U.S. Attorney, is investigating certain officers and directors of the LHC Group (NASDAQ: LHCG) for possible breaches of fiduciary duty and other federal and state laws. The firma™s investigation seeks to determine whether LHC and its directors and officers breached their fiduciary duties by causing or allowing it to unfairly take advantage of the Medicare reimbursement system. Shareholders familiar with the investigation are urged to contact the Kendall Law Group for more information at 877-744-3728 or by email at [ skendall@kendalllawgroup.com ].

"determine whether the companies deliberately boosted the number of home therapy visits to trigger higher Medicare reimbursements"

On April 26, 2010, the Wall Street Journal (Journal) published an article describing increased in-home visits billed to Medicare by Amedisys (NASDAQ: AMED). The Journal hired Henry Dove, a professor at Yale Universitya™s School of Public Health, to analyze the number of Medicare home visits from various health care companies and to determine awhether the number of visits coincided with Medicare financial incentives.a Professor Dove determined that athe pattern of clustering visits at reimbursement trigger points was industry widea and that after the 10 visit $2,200 bonus payment were eliminated in January 2008, LHCa™s percentage of patients getting 10 visits dropped 64%. Shortly after the article was released, the Senate Finance Committee launched an investigation to adetermine whether the companies deliberately boosted the number of home therapy visits to trigger higher Medicare reimbursementsa and LHC confirmed that they received inquiry letters. LHC share prices fell 11% immediately following the disclosure of a Securities and Exchange Commission investigation concerning Amedisys and its Medicare billing practices on July 1, 2010.

Kendall Law Group has the credentials and experience to pursue any type of complex securities litigation in the nation. The firm is a national securities firm that represents shareholders when publicly traded companies violate the law. Shareholders are encouraged to contact attorney Scott Kendall for more information.

Contributing Sources